Biora Therapeutics

IN THE PRESS

Biotech Beach

Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset

March 11, 2024

·

5 min read

Drug Development

Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600

February 26, 2024

·

7 min read

Biotech Beach

Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium

February 8, 2024

·

3 min read

Biotech Beach

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

January 22, 2024

·

3 min read

Biotech Beach

Biora Therapeutics Provides Outlook for 2024

January 16, 2024

·

7 min read

Drug Development

Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600

January 8, 2024

·

6 min read

Drug Development

Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery PlatformBioJet device exceeded performance targets for delivery of collaborator AstraZeneca’s molecule in preclinical study

January 2, 2024

·

5 min read

Biotech Beach

Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform

December 19, 2023

·

6 min read

Biotech Beach

Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors

December 18, 2023

·

5 min read

Business

Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

December 11, 2023

·

4 min read

JOBS